Science Explorer Back to mapMap

Most cited papers from Integra LifeSciences (United States)

What are the most cited papers from Integra LifeSciences (United States)?

The most cited paper from Integra LifeSciences (United States) is "An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds" (Samuel R. Nussbaum, Marissa Janine Carter, Caroline E. Fife et al., 2017), with 1,224 citations. Next come "Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease" (484) and "Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial" (405).

Showing 50 of 60 papers. Every paper with more than 44 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds Samuel R. Nussbaum, Marissa Janine Carter, Caroline E. Fife et al. · Value in Health Open access 20 Sep 2017 1,224
2 Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease Melanie Ann Felmlee, Robert S. Jones, Vivian Rodriguez‐Cruz et al. · Pharmacological Reviews Open access 6 Mar 2020 484
3 Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial Gilmar Reis et al. · The Lancet Global Health Open access 28 Oct 2021 405
4 The New Reconstructive Ladder: Modifications to the Traditional Model Jeffrey E. Janis, Robert K. Kwon, Christopher E. Attinger · Plastic & Reconstructive Surgery 2011 275
5 Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load António Gonçalves, Julie Bertrand, Ruian Ke et al. · CPT Pharmacometrics & Systems Pharmacology Open access 18 Jun 2020 239
6 How COVID-19 has fundamentally changed clinical research in global health Jay Park, Robin Mogg, Gerald E. Smith et al. · The Lancet Global Health Open access 16 Apr 2021 227
7 Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy Adam S. Darwich, Thomas M. Polasek, Jeffrey K Aronson et al. · The Annual Review of Pharmacology and Toxicology ReviewOpen access 9 Oct 2020 197
8 In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants Monica Ramchandani, Dennis H. Robinson · Journal of Controlled Release Jul 1998 194
9 Control of hepatocyte function on collagen foams: sizing matrix pores toward selective induction of 2-D and 3-D cellular morphogenesis Colette S. Ranucci, Ajay Kumar, Surendra P Batra et al. · Biomaterials Apr 2000 192
10 Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries Jeannette E. Davies, Xiufeng Tang, Jeremy W. Denning et al. · European Journal of Neuroscience Mar 2004 189
11 Early Treatment with Pegylated Interferon Lambda for Covid-19 Gilmar Reis et al. · New England Journal of Medicine Open access 8 Feb 2023 179
12 Factors that influence peripheral nerve regeneration: An electrophysiological study of the monkey median nerve Christian Krarup, Simon J. Archibald, Roger D. Madison · Annals of Neurology 3 Dec 2001 172
13 Chronic wound prevalence and the associated cost of treatment in Medicare beneficiaries: changes between 2014 and 2019 Marissa Janine Carter, Joan DaVanzo, Randall Haught et al. · Journal of Medical Economics Open access 7 Jul 2023 167
14 Orthopaedic biofilm infections Paul Stoodley, Garth D. Ehrlich, Parish Paymon Sedghizadeh et al. · Current Orthopaedic Practice Open access 4 Oct 2011 163
15 TCDD-Inducible Poly(ADP-ribose) Polymerase: A Novel Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Qiang Ma, Kimberly T. Baldwin, Anthony J. Renzelli et al. · Biochemical and Biophysical Research Communications Nov 2001 157
16 Integrin α IIb β 3 Inhibitor Preserves Microvascular Patency in Experimental Acute Focal Cerebral Ischemia Takeo Abumiya, Robert Fitridge, Curt Mazur et al. · Stroke Open access Jun 2000 139
17 Development of Near Zero-Order Release Dosage Forms Using Three-Dimensional Printing (3-DP™) Technology Chen-Chao Wang, Monica R. Tejwani, Willie J. Roach et al. · Drug Development and Industrial Pharmacy 2006 118
18 An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response Erin R. Steenblock, Tarek R. Fadel, Michael J. Labowsky et al. · Journal of Biological Chemistry Open access 18 Aug 2011 111
19 Surgery versus conservative treatment for traumatic acute subdural haematoma: a prospective, multicentre, observational, comparative effectiveness study Thomas Arjan van Essen et al. · The Lancet Neurology Open access255 authors 5 May 2022 110
20 A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers Patrick F. Smith, Janakan Krishnarajah, Philip A. Nunn et al. · British Journal of Clinical Pharmacology Open access 21 Jun 2017 105
21 Effects of growth-factor-enhanced culture on a chondrocyte-collagen implant for cartilage repair Brian C. Toolan, Sally R. Frenkel, James M. Pachence et al. · Journal of Biomedical Materials Research Jun 1996 105
22 Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa B. Alexander Yi, Debra Freedholm, Nancy Widener et al. · Journal of Thrombosis and Haemostasis Open access 29 Oct 2021 104
23 Collagen Conduit Versus Microsurgical Neurorrhaphy: 2-Year Follow-Up of a Prospective, Blinded Clinical and Electrophysiological Multicenter Randomized, Controlled Trial Michel E. H. Boeckstyns, Allan Ibsen Sørensen, Joaquin Fores Viñeta et al. · The Journal Of Hand Surgery 5 Nov 2013 103
24 Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India Alan Hall Jobe, Mark A. Milad, Thomas Peppard et al. · Clinical and Translational Science Open access 6 Dec 2019 102
25 Engineered cellular response to scaffold architecture in a rabbit trephine defect Joshua L. Simon, Tithi Dutta Roy, John Russell Parsons et al. · Journal of Biomedical Materials Research Part A 14 Jul 2003 99
26 Artificial Intelligence and Machine Learning Applied at the Point of Care Zuzanna Angehrn, Liina Haldna, Anthe S. Zandvliet et al. · Frontiers in Pharmacology Open access 18 Jun 2020 93
27 A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy James R. Myette, Toshiki Kano, Hitoshi Suzuki et al. · Kidney International Open access 16 Mar 2019 92
28 Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study Ellie Hershberger, Susan E. Sloan, Kristin M. Narayan et al. · EBioMedicine Open access 9 Jan 2019 88
29 Nonlinear Mixed‐Effects Model Development and Simulation Using nlmixr and Related R Open‐Source Packages Matthew L. Fidler, Justin J. Wilkins, Richard Hooijmaijers et al. · CPT Pharmacometrics & Systems Pharmacology Open access 17 Jun 2019 85
30 Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters Brahim Achour, Zubida M. Al‐Majdoub, Agnieszka Grybos‐Gajniak et al. · Clinical Pharmacology & Therapeutics Open access 3 Nov 2020 84
31 Development of a Multicompartment Permeability‐Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs Lu Gaohua, J. R. Wedagedera, Ben G. Small et al. · CPT Pharmacometrics & Systems Pharmacology Open access Oct 2015 84
32 The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants Monica Ramchandani, Marvin C. Pankaskie, Dennis H. Robinson · Journal of Controlled Release 1997 84
33 Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future Craig R. Rayner, Patrick F. Smith, David R. Andes et al. · Clinical Pharmacology & Therapeutics Open access 9 Feb 2021 78
34 Standardized criterion to analyze and directly compare various materials and models for peripheral nerve regeneration Ioannis V. Yannas, Mei Zhang, Mark H. Spilker · Journal of Biomaterials Science Polymer Edition 2007 77
35 Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization John J. Grzesiak, Michael D. Pierschbacher, Mario F. Amodeo et al. · Biomaterials Dec 1997 76
36 Safe Tourniquet Use: A Review of the Evidence Peter G. Fitzgibbons, Christopher W. DiGiovanni, Sayed Hares et al. · Journal of the American Academy of Orthopaedic Surgeons May 2012 75
37 Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review Ranita Kirubakaran, SOPHIE LENA STOCKER, Stefanie Hennig et al. · Clinical Pharmacokinetics ReviewOpen access 11 Aug 2020 74
38 Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models André Dallmann, Marc Pfister, John van den Anker et al. · Clinical Pharmacology & Therapeutics Review 10 Apr 2018 72
39 Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance John O. Miners, Thomas M. Polasek, Julie-Ann Hulin et al. · Pharmacology & Therapeutics 30 May 2023 67
40 Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2‐Positive Breast Cancer and Other Solid Tumors Ophelia Q. P. Yin, Yuan Xiong, Seiko Endo et al. · Clinical Pharmacology & Therapeutics Open access 29 Oct 2020 65
41 Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons Kenneth H. Minor, Xiufeng Tang, Genevieve A. Kahrilas et al. · Neurobiology of Disease Open access 27 Jun 2008 65
42 Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network L. Cucurull-Sanchez, Michael John Chappell, Vijayalakshmi Chelliah et al. · CPT Pharmacometrics & Systems Pharmacology Open access 23 Jan 2019 63
43 Virtual Twins: Understanding the Data Required for Model‐Informed Precision Dosing Thomas M. Polasek, Amin Rostami‐Hodjegan · Clinical Pharmacology & Therapeutics 14 Feb 2020 61
44 Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response Stephanus T. Malherbe et al. · EJNMMI Research Open access 10 Feb 2020 57
45 Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan Ophelia Q. P. Yin, Hiroji Iwata, Chia‐Chi Lin et al. · Clinical Pharmacology & Therapeutics Open access 17 May 2021 56
46 Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma Ken Ogasawara, Michael Dodds, Timothy R. Mack et al. · Clinical Pharmacokinetics Open access 14 Jun 2021 54
47 Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients Rachael A. Lawson, Christine E. Staatz, Christopher J. Fraser et al. · Clinical Pharmacokinetics 30 Oct 2020 54
48 Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168) Timothy D. Owens, Patrick F. Smith, Andrew David Redfern et al. · Clinical and Translational Science Open access Nov 2021 53
49 In vitro comparison of wear characteristics of PyroCarbon and metal on bone: Shoulder hemiarthroplasty Jerome J. Klawitter, Jason Patton, Robert B. More et al. · Shoulder & Elbow Open access 11 Sep 2018 53
50 Global regulatory registration requirements for collagen-based combination products: points to consider J.E. O’Grady · Advanced Drug Delivery Reviews 22 Oct 2003 53

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.